Evidence map›Paper›PMID 38098662›Full record

ArticleFrontiers in microbiology2023

High risk HPV-positive women cervicovaginal microbial profiles in a Greek cohort: a retrospective analysis of the GRECOSELF study.

Electra Sofou, Glykeria Gkoliou, Nikolaos Pechlivanis, Konstantinos Pasentsis, Kimon Chatzistamatiou, Fotis Psomopoulos, Theodoros Agorastos, Kostas Stamatopoulos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Electra Sofou *Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Glykeria Gkoliou *Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Nikolaos PechlivanisInstitute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Konstantinos PasentsisInstitute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Kimon Chatzistamatiou1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece.
Fotis PsomopoulosInstitute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Theodoros AgorastosSt. Luke's Hospital, Thessaloniki, Greece.
Kostas StamatopoulosInstitute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence supports a role for the vaginal microbiome (VM) in the severity of HPV infection and its potential link to cervical intraepithelial neoplasia. However, a lot remains unclear regarding the precise role of certain bacteria in the context of HPV positivity and persistence of infection. Here, using next generation sequencing (NGS), we comprehensively profiled the VM in a series of 877 women who tested positive for at least one high risk HPV (hrHPV) type with the COBAS

Indexed as

cervical microbiomeHPVLacticaseibacillusnext generation sequencing (NGS)vaginal microbiome

Identifiers

PMID38098662
PMCPMC10720629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.